Research

Hormonal

Phenotype-guided prescribing of anti-obesity medications (matching drug to underlying pathophysiology like 'hungry brain' or 'hungry gut') results in significantly greater weight loss compared to standard non-phenotype-guided care.

If standard weight loss medications aren't working well, ask your doctor about 'phenotype-guided' prescribing. This involves identifying whether your obesity is driven by 'hungry brain' (satiety issues), 'hungry gut' (satiety signals), 'emotional hunger', or 'slow burn' (metabolism). Matching the right drug (like Phentermine/Topiramate for hungry brain or Liraglutide for hungry gut) to your specific type can nearly double your chances of losing more than 10% of your body weight compared to standard care.

ModerateSupportsMEDIUM confidence
The phenotype‐guided prescription resulted in a 1.75‐fold greater weight loss compared with the non‐phenotype‐guided group (15% vs 9%), and 79% vs 34% achieved >10% weight loss in the phenotype‐guided vs non‐phenotype‐guided (standard care) groups
Win Min Oo et al. · Expert Opinion on Pharmacotherapy · 2022

Why this rating

Based on a single pragmatic real-world trial (Mayo Clinic) requiring replication in larger cohorts.

Source

A narrative review of anti-obesity medications for obese patients with osteoarthritis

Win Min Oo et al. · Expert Opinion on Pharmacotherapy · 2022

DOI 10.1080/14656566.2022.2104636

narrative_reviewCited 9×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →